PRMT5 and renal cell carcinoma: Additionally, Kaplan–Meier survival curves demonstrated that high PRMT5 expression was strongly associated with poor overall survival (OS) (P < 0.001) and disease-free survival (DFS) (P < 0.001) in RCC patients (Fig. 6B and C).